Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Pediatric Gastroenterology, Hepatology & Nutrition ; : 35-48, 2020.
Article in English | WPRIM | ID: wpr-782186

ABSTRACT

6 years (RR=4.15), with previous abdominal pain (RR=7.2) or constipation (RR=4.06). Constipation was recorded in 23/289 (8.0%), with increased risk in children having surgery (RR=2.56) or previous constipation (RR=7.38). Probiotic supplementation significantly reduced AAD (RR=0.30) and abdominal pain (RR=0.36). Lactobacillus rhamnosus GG (LGG) and L. reuteri significantly reduced AAD (RR=0.37 and 0.35) and abdominal pain (RR=0.37 and 0.24).CONCLUSION: AAD occurred in 20.4% of children, with increased risk at younger age, lower respiratory and urinary tract infections, intravenous treatment and previous AAD. LGG and L. reuteri reduced both AAD and associated abdominal pain.


Subject(s)
Child , Humans , Abdominal Pain , Administration, Intravenous , Anti-Bacterial Agents , Constipation , Diarrhea , Incidence , Inpatients , Limosilactobacillus reuteri , Lacticaseibacillus rhamnosus , Probiotics , Prospective Studies , Protective Factors , Urinary Tract Infections
SELECTION OF CITATIONS
SEARCH DETAIL